Lumiliximab Biosimilar - Anti-CD23 Antibody - BSA and Azide free (A338516)

Lumiliximab Biosimilar - Anti-CD23 Antibody - BSA and Azide free

Chimeric monoclonal antibody to CD23. Research grade Lumiliximab biosimilar.

ELISA, Flow Cytometry, Functional Studies, in vivo Research

Human

Chimeric

Monoclonal

IgG1

The purity of this Biosimilar is >95%, as determined by SDS-PAGE.

Liquid

Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.

Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).

BLAST-2, C-type lectin domain family 4 member J, CD23A, CLEC4J, Fc-epsilon-RII, FCE2, FCER2, IGEBF, Immunoglobulin E-binding factor, Low affinity immunoglobulin epsilon Fc receptor, Lymphocyte IgE receptor

This product is for research use only. It is not intended for diagnostic or therapeutic use.